D-744-2014 Class III Terminated

Recalled by Novartis Consumer Health — Lincoln, NE

FDA drug recall D-744-2014 was initiated by Novartis Consumer Health on May 15, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 2,978,000/2-caplet packages.

Recall details

Product Type
Drugs
Report Date
Jan 22, 2014
Initiation Date
May 15, 2013
Termination Date
Nov 4, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,978,000/2-caplet packages

Product description

Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.

Reason for recall

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

Distribution pattern

Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.

Code information

Lot# 10118234 Exp 05/13 Lot# 10120254 Exp 05/13 Lot# 10123513 Exp 08/13 Lot#10125262 Exp 09/13

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-744-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-744-2014. Report a data issue: hello@regdatalab.com.